论文部分内容阅读
目的探讨钼靶影像对乳腺癌T分期的价值。方法136例乳腺癌患者按照影像表现被分为3组:第1组(65例)为单纯肿块型或合并钙化而钙化未超出肿块范围者;第2组(49例)为肿块合并毛刺者;第3组(22例)为单纯钙化或肿块合并钙化而钙化超出肿瘤边界者。术前1周内经临床触诊和钼靶X线测量肿瘤大小,并与术后病理测量的肿瘤大小相比较。结果第1组3种测量方法无显著差异;第2组触诊与病理之间有非常显著差异(P<0.05),影像与病理有显著差异(P<0.05);第3组触诊与病理之间有非常显著差异(P<0.05),影像与病理无显著差异(P>0.5)。结论钼靶影像对乳腺癌术前T分期具有明显优势,能更客观地为临床医师提供诊疗依据。
Objective To investigate the value of mammography in T staging of breast cancer. Methods One hundred and sixty-six breast cancer patients were divided into three groups according to the imaging findings: group 1 (65 cases) was simple mass or calcification without calcification exceeding the mass; group 2 (49 cases) Group 3 (n = 22) was calcified or lump calcified with calcifications beyond the tumor border. Tumor size was measured by clinical palpation and mammography X-ray within 1 week before surgery, and compared with the size of the tumor pathologically measured postoperatively. Results There was no significant difference between the three methods in the first group (P <0.05). There was a significant difference between palpation and pathology in the second group (P <0.05) (P <0.05), there was no significant difference between the imaging and pathology (P> 0.5). Conclusion Molybdenum target images have obvious advantages for preoperative T staging of breast cancer, which can provide clinicians more objective diagnosis and treatment.